Mier JW - Search Results

1

Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedure.

Ryan T, Atkins MB, Mier JW, Berkman EM. Ryan T, et al. Among authors: mier jw. Transfusion. 1989 Jul-Aug;29(6):491-5. doi: 10.1046/j.1537-2995.1989.29689318445.x. Transfusion. 1989. PMID: 2787549

2

Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells.

Mier JW, Aronson FR, Numerof RP, Vachino G, Atkins MB. Mier JW, et al. Pathol Immunopathol Res. 1988;7(6):459-76. doi: 10.1159/000157075. Pathol Immunopathol Res. 1988. PMID: 2976936 Review.

3

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.

Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Atkins MB, et al. Among authors: mier jw. N Engl J Med. 1988 Jun 16;318(24):1557-63. doi: 10.1056/NEJM198806163182401. N Engl J Med. 1988. PMID: 3259674

4

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Mier JW, Vachino G, van der Meer JW, Numerof RP, Adams S, Cannon JG, Bernheim HA, Atkins MB, Parkinson DR, Dinarello CA. Mier JW, et al. J Clin Immunol. 1988 Nov;8(6):426-36. doi: 10.1007/BF00916947. J Clin Immunol. 1988. PMID: 3265420

5

Interleukin-6-associated anemia: determination of the underlying mechanism.

Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM. Atkins MB, et al. Among authors: mier jw. Blood. 1995 Aug 15;86(4):1288-91. Blood. 1995. PMID: 7632934 Free article. Clinical Trial.

6

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: mier jw. Blood. 1994 Jan 1;83(1):113-8. Blood. 1994. PMID: 8274730 Free article. Clinical Trial.

7

Possible myocardial toxicity associated with interleukin-4 therapy.

Trehu EG, Isner JM, Mier JW, Karp DD, Atkins MB. Trehu EG, et al. Among authors: mier jw. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):348-51. doi: 10.1097/00002371-199311000-00015. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280718

8

Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.

Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: mier jw. J Immunol. 1993 Sep 15;151(6):3299-307. J Immunol. 1993. PMID: 8397255

9

Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters.

Vogelzang PJ, Bloom SM, Mier JW, Atkins MB. Vogelzang PJ, et al. Among authors: mier jw. Chest. 1992 Mar;101(3):746-52. doi: 10.1378/chest.101.3.746. Chest. 1992. PMID: 1541142

10

Augmentation of insulin autoantibodies following interleukin-2 and lymphokine activated killer cell therapy.

Bergstrom RW, Atkins MB, Mier JW, Palmer JP. Bergstrom RW, et al. Among authors: mier jw. J Clin Lab Immunol. 1990 Apr;31(4):189-93. J Clin Lab Immunol. 1990. PMID: 1967063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters